Human medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation: 25/10/2005, Revision: 53, Status: Authorised
Applications for new human medicines under evaluation: June 2026
Presentations - EnprEMA& ACT EU workshop on paediatric clinical trials
Data protection notice for legal entity and bank account validation regarding payments
Agenda - Clinical trials information system information day webinar
Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 26, Status: Authorised
Minutes of PRAC meeting on 7-10 April 2026
Report - HMA/EMA multi-stakeholder workshop on reporting and qualification of mechanistic models for regulatory assessment
PSUSA/00000491/202506
Member states contact points for translations review